Home    Resource Store    Past Issues    Buyers' Guide    Career Center    Subscriptions    Advertising    E-Newsletter    Contact

http://www.allstatestextile.com
http://www.textileworld.com/partners/Sr_Sales_Representative_Bolger_and_OHearn_Inc?override_sig=6d134c277189eb53ad63648042f76d28&override_token=b65bbcb705ed6642a8800553cd8f0acf
http://www.LookChina.com
http://www.expoproduccion.mx/Content/Exhibitors/24/
http://www.textileservicesonline.com
http://www.textileworld.com/forms/mediakit.html
Textile World Photo Galleries
September/October 2014 Sept/Oct 2014

View Issue  |

Subscribe Now  |

Events

Advanced Nonwovens Training Course
10/28/2014 - 10/30/2014

JEC Americas Composites Conferences
10/28/2014 - 10/29/2014

73rd ICAC Plenary Meeting
11/02/2014 - 11/07/2014

- more events -

- submit your event -

Printer Friendly
Full Site
Fiber World

UMC Utrecht Selects Dyneema Purity® For Heart Valve Development

Biomedical materials science company Royal DSM NV and the University Medical Center of Utrecht (UMC Utrecht), both based in the Netherlands, have signed a collaborative agreement under which DSM will provide its Dyneema Purity® fiber technology to UMC Utrecht for the development and evaluation of a prototype of a non-biological support scaffold for use in minimally invasive treatment of valvular and vascular disease.

UMC Utrecht selected Dyneema Purity to use in this development based on the fiber's high strength and flex fatigue resistance, tear resistance, low elongation, and minimal profile.

"We believe that heart valves with scaffolding made from Dyneema Purity® fibers have the potential to lead to a revolutionary new solution, giving those dealing with heart disease the benefit of a less invasive transcatheter heart valve replacement," said Paul Gründeman, M.D., Ph.D., principal investigator, Heart and Lungs Division, UMC Utrecht. "Although we are in a very early feasibility stage and prototyping only, we believe Dyneema Purity fiber is a very interesting material to use as basis for this feasibility study."

March/April 2012

Advertisement